95.7%
tafamidistolcaponepatisiranATTRv amyloidosisCNS/leptomeningeal amyloidosisGly53Ala ATTRv amyloidosisCNS amyloidosis
… and that, in our patient with Gly53Ala ATTRv amyloidosis, 61mg tafamidis therapy may not prevent CNS progression. He is planned to be co…